Novartis
NVS
NVS
1,118 hedge funds and large institutions have $19.8B invested in Novartis in 2021 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 401 increasing their positions, 411 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,118
Holders Change
-16
Holders Change %
-1.41%
% of All Funds
19.52%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
73
Increased
401
Reduced
411
Closed
79
Calls
$251M
Puts
$110M
Net Calls
+$140M
Net Calls Change
+$24.5M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
$2.23B |
| 2 |
Two Sigma Advisers
New York
|
$173M |
| 3 |
Two Sigma Investments
New York
|
$143M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
$575M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
$909M |
